Search results

Technologies 1

• CogniXense: A Platform for Rapid Drug Repurposing
  CogniXense is a target-agnostic drug discovery platform that enables the repurposing of drugs for rare genetic diseases in record time. By combining human data-based computational drug prediction with on-demand animal model development, we can mimic the diversity of symptoms of patient populations and begin drug screening on new diseases within a month.

News 17

View all

• Press Release
  
  Reversing age by reprogramming gene expression networks
  October 14, 2026
• Press Release
  
  Pulling carbon into seawater using engineered bacteria
  August 28, 2026
• Press Release
  
  Materializing safe, on-demand living therapeutics
  May 14, 2026

Multimedia 1

• 

  Video/Animation
  CogniXense: Speeding Up Treatments for Rare Diseases
  At the Wyss Institute, we are tackling Rett syndrome, a rare disease that affects 1 out of 9,000 children, by developing a scalable model for neurodevelopmental and cognitive diseases. This model can test drugs to see which will improve memory, learning, and behavior, with the end goal of finding effective therapies. Credit: Wyss Institute at...